Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia

NCT01850420 is registered in ClinicalTrials.gov with Innovative Med Concepts, LLC as lead sponsor.

NCT NCT01850420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01850420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blinded, Randomized, Placebo-Controlled, Proof of Concept Phase 2a Study Exploring the Safety and Efficacy of IMC-1 for the Treatment of Patients With Fibromyalgia
Lead sponsor
Innovative Med Concepts, LLC
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2013
Completion date
March 31, 2014
Enrollment
143 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pain, fibromyalgia, myofascial pain